Reduction in renal outcomes with selective endothelin receptor antagonist in patients with diabetic kidney disease3' education - Apr. 17, 2019 - Melbourne, Australia
This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.
Prof. dr. Hiddo Lambers Heerspink is clinical pharmacologist and works at the faculty Medical Sciences, University Groningen, the Netherlands
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.